Truist Financial raised its price target for Progyny to $36, signaling nearly 40% upside from its current price. This follows Progyny's record quarterly revenue of $350.51 million, earnings per share of $0.55 beating estimates, and strong client retention. Large institutional investors, including California State Teachers Retirement System, are significantly increasing their stakes, indicating confidence in Progyny's long-term growth. The company is well positioned for the 2027 selling season with positive market outlook.
IperionX Limited is viewed positively due to the scarcity of domestic titanium production and strong economics of its Titan Critical Minerals Project. The company's integrated approach, from titanium powder to components, adds value and is supported ...
XRP price fell below $1 twice this week, but on-chain data shows a surge in withdrawals from exchanges, especially Binance, reaching the highest levels since 2019. Large XRP holders, or whales, have increased their holdings to over 12 billion tokens ...
Lucid's stock has seen volatile swings recently, with a shift toward bearish sentiment after its August earnings report missed revenue and loss expectations. Despite a July surge fueled by confidence from a Saudi royal investor, the company's quarter...
Uber and Chinese autonomous vehicle maker Pony.ai have announced plans to introduce 2,000 robotaxis in four European cities as part of their expanded partnership. Pony.ai will provide the autonomous driving technology, while Uber will leverage its ri...
Public Bitcoin miners have cut their hashrate by 13.4%, signaling a reduction in their mining activity or capacity. Meanwhile, revenue from AI infrastructure has grown, indicating increased investment or demand in that sector. This shift highlights a...
